TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 19 | -97.3% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 700 | -50.9% | 0.00% | – |
| Q4 2018 | $2,000 | -75.0% | 1,426 | -50.9% | 0.00% | – |
| Q3 2018 | $8,000 | +60.0% | 2,902 | +94.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 1,496 | -7.5% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 1,618 | +36.3% | 0.00% | – |
| Q4 2017 | $7,000 | +40.0% | 1,187 | +65.3% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 718 | +2.6% | 0.00% | – |
| Q2 2017 | $5,000 | -16.7% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -94.2% | 700 | -97.2% | 0.00% | – |
| Q4 2016 | $103,000 | +1187.5% | 24,689 | +1024.3% | 0.00% | – |
| Q3 2016 | $8,000 | +166.7% | 2,196 | +211.9% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 704 | +87.7% | 0.00% | – |
| Q1 2016 | $2,000 | -97.6% | 375 | -95.5% | 0.00% | – |
| Q4 2015 | $84,000 | -95.2% | 8,362 | -96.5% | 0.00% | -100.0% |
| Q3 2015 | $1,764,000 | -78.9% | 236,378 | +33.8% | 0.00% | -80.0% |
| Q2 2015 | $8,378,000 | +29.0% | 176,607 | -0.4% | 0.01% | +25.0% |
| Q1 2015 | $6,495,000 | +129800.0% | 177,250 | +49136.1% | 0.01% | – |
| Q2 2014 | $5,000 | 0.0% | 360 | -44.6% | 0.00% | – |
| Q2 2013 | $5,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |